Filters

See more specimen types...
See more states

Other countries

Results: 1 to 20 of 369 (representing 22 labs)

Tests names and labsConditionsGenes and analytesMethods

CentoCancer panel

Centogene AG - the Rare Disease Company
Germany
5231
  • C Sequence analysis of the entire coding region

Prostate cancer panel

Centogene AG - the Rare Disease Company
Germany
110
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Prostate cancer, familial, association with

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Breast cancer

Centogene AG - the Rare Disease Company
Germany
61
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Hereditary Cancer Panel - High Penetrance 16

Molecular Genetics Laboratory London Health Sciences Centre
Canada
2816
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

Solid Tumor Panel

Centogene AG - the Rare Disease Company
Germany
4062
  • C Sequence analysis of the entire coding region

Cancer Hotspot Panel

Centogene AG - the Rare Disease Company
Germany
4688
  • E Sequence analysis of select exons

Myeloid Tumor Panel

Centogene AG - the Rare Disease Company
Germany
3253
  • X Mutation scanning of select exons

Prostate cancer, somatic

Centogene AG - the Rare Disease Company
Germany
11
  • C Sequence analysis of the entire coding region

Prostate cancer

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Ovarian Cancer Sequencing and Deletion/Duplication Panel

PreventionGenetics
United States
3521
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Prolaris

Myriad Genetic Laboratories, Inc.
United States
11
  • R RNA analysis

BrainTumorNext

Ambry Genetics
United States
7727
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CustomNext-Cancer

Ambry Genetics
United States
6867
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Breast and Ovarian Cancer BRCA1/2 Sequencing and Deletion/Duplication Panel

PreventionGenetics
United States
42
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Kennedy Disease Repeat Expansion Analysis

Baylor Miraca Genetics Laboratories Baylor College of Medicine
United States
51
  • T Targeted variant analysis

AR Sequence Analysis (Prenatal Diagnosis)

Baylor Miraca Genetics Laboratories Baylor College of Medicine
United States
51
  • T Targeted variant analysis

AR Sequence Analysis (Familial Mutation/Variant Analysis)

Baylor Miraca Genetics Laboratories Baylor College of Medicine
United States
51
  • T Targeted variant analysis

AR Sequence Analysis

Baylor Miraca Genetics Laboratories Baylor College of Medicine
United States
51
  • C Sequence analysis of the entire coding region

MitoMet®Plus aCGH Analysis

Baylor Miraca Genetics Laboratories Baylor College of Medicine
United States
845637
  • D Deletion/duplication analysis

Results: 1 to 20 of 369

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center